I have a point of order, Mr. Chair.
Thank you, Doctor. I will say I appreciate your point of view.
I'm going to close with a comment. One of the comments you did make in your testimony was that you would defer to people who are the experts in nuclear medicine, and I believe we have one of those people here. Dr. Gulenchyn provided that testimony. You are completely ignoring the small-market impacts of what happened in some of the smaller centres, and I believe that is very important to the health care of Canadians.
Thank you, Mr. Chair.